GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stake Lowered by Quadrant Private Wealth Management LLC

Quadrant Private Wealth Management LLC cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,641 shares of the company’s stock after selling 269 shares during the quarter. Quadrant Private Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $519,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. LGT Financial Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 1,673.3% during the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the last quarter. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Capital Performance Advisors LLP bought a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $26,000. Darwin Wealth Management LLC bought a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $31,000. Finally, Continuum Advisory LLC grew its holdings in shares of GE HealthCare Technologies by 101.8% during the third quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the company. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company increased their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Citigroup increased their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday. One research analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $97.85.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ GEHC opened at $92.21 on Friday. The stock has a fifty day moving average price of $84.03 and a two-hundred day moving average price of $85.51. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. The firm has a market cap of $42.13 billion, a P/E ratio of 25.33, a PEG ratio of 2.93 and a beta of 1.15. GE HealthCare Technologies Inc. has a 1 year low of $74.51 and a 1 year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th were given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date of this dividend was Tuesday, January 14th. This is an increase from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio is 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.